These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. New PI active against many strains. AIDS Patient Care STDS; 1999 Sep; 13(9):568. PubMed ID: 10813041 [No Abstract] [Full Text] [Related]
3. On the issue of cross-resistance between protease inhibitors. Birch C AIDS; 1998 Apr; 12(6):680-1. PubMed ID: 9583615 [No Abstract] [Full Text] [Related]
5. Sequence and drug susceptibility of subtype C protease from human immunodeficiency virus type 1 seroconverters in Zimbabwe. Shafer RW; Chuang TK; Hsu P; White CB; Katzenstein DA AIDS Res Hum Retroviruses; 1999 Jan; 15(1):65-9. PubMed ID: 10024054 [No Abstract] [Full Text] [Related]
7. [Kynostatin (KNI)-272--a rationally designed tripeptide inhibitor of HIV protease]. Kiso Y Nihon Rinsho; 1993 Sep; 51 Suppl():139-45. PubMed ID: 8271377 [No Abstract] [Full Text] [Related]
8. Resistance and cross-resistance with saquinavir and other HIV protease inhibitors: theory and practice. Roberts NA; Craig JC; Sheldon J AIDS; 1998 Mar; 12(5):453-60. PubMed ID: 9543442 [No Abstract] [Full Text] [Related]
9. Orally bioavailable highly potent HIV protease inhibitors against PI-resistant virus. Lu Z; Bohn J; Rano T; Rutkowski CA; Simcoe AL; Olsen DB; Schleif WA; Carella A; Gabryelski L; Jin L; Lin JH; Emini E; Chapman K; Tata JR Bioorg Med Chem Lett; 2005 Dec; 15(23):5311-4. PubMed ID: 16203148 [TBL] [Abstract][Full Text] [Related]
10. Resistance: a shifting paradigm. Jenny-Avital ER AIDS Clin Care; 2002 Dec; 14(12):106. PubMed ID: 12510656 [No Abstract] [Full Text] [Related]
11. What's new in HIV. Morris-Jones S; Nelson MR J Infect; 1999 Mar; 38(2):i-ii. PubMed ID: 10342641 [No Abstract] [Full Text] [Related]